Institute of Cancer Research

Making the discoveries that defeat cancer

Paul Workman on innovation

Watch the video from Innovation Debate

Research Divisions

Find out about our eight scientific divisions

Science Students

PhD studentships available

Clinical Trainees

Opportunities & support

Current Students

Available Supporting Resources

Staff Development

Training and Learning

Staff Benefits

Welfare and Facilities

Job Vacancies

Current vacancies

Legacies

Contribute to the future.

Student Bursary Programme

Opportunities

View our licensing portfolio

Successes

ICR’s enterprise achievements

Contacts

Get in touch with us

News

Pioneering drug for advanced prostate cancer has major benefit for earlier disease too
[11 December 2012]
Prostate cancer drug benefits earlier-stage disease

Genome profiling for cancer patients
[10 December 2012]
The ICR welcomes £100m Government investment in high-tech genome profiling for cancer patients.

Fewer, bigger doses of radiotherapy benefit breast cancer patients
[06 December 2012]
Women diagnosed with breast cancer can benefit from receiving fewer but higher doses of radiotherapy than is t...

Kidney cancer genetic risk discovery
[05 December 2012]
Scientists at the ICR have found a new genetic variation which increases a person’s risk of developing the mos...

The Royal Marsden and The Institute of Cancer Research open groundbreaking facility bringing smart trials to the NHS
[20 November 2012]
Scientists will monitor whether new-generation cancer drugs are successfully hitting their targets by simply p...

Professor Paul Workman to join Innovation Debate 2012
[19 November 2012]
Professor Paul Workman, Deputy Chief Executive and head of cancer therapeutics at The Institute of Cancer Rese...

£1.2m grant to develop ICR-discovered drug
[12 November 2012]
Professor Paul Workman, deputy chief executive of The Institute of Cancer Research, has welcomed the news that...

Zelboraf recommended for NHS patients
[02 November 2012]
Professor Alan Ashworth, chief executive of The Institute of Cancer Research, London, comments on the announce...

Scientists develop ‘barcode’ blood test for aggressive prostate cancer
[09 October 2012]
Scientists have designed a blood test that reads genetic changes like a barcode – and can pick out aggressive ...

Fibonacci sequence inspires new brand identity for The Institute of Cancer Research
[05 October 2012]
The Fibonacci* sequence and images inspired by science and medicine feature prominently in a bold rebranding o...